Literature DB >> 9831473

Two novel presenilin-1 mutations (Ser169Leu and Pro436Gln) associated with very early onset Alzheimer's disease.

K Taddei1, J B Kwok, J J Kril, G M Halliday, H Creasey, M Hallupp, C Fisher, W S Brooks, C Chung, C Andrews, C L Masters, P R Schofield, R N Martins.   

Abstract

Mutations in the presenilin-1 (PS-1) gene account for the majority of early onset autosomal-dominant familial Alzheimer's disease (FAD) cases. We identified three missense mutations in the coding sequence of the PS-1 gene in three early onset (EO), FAD pedigrees. Alzheimer's disease was confirmed in one pedigree by autopsy. Mutation analysis of PCR products amplified from genomic DNA templates of affected individuals showed two novel mutations resulting in Ser169Leu and Pro436Gln and one known mutation resulting in Glu318Gly. The two new mutations are located within predicted transmembrane domains three (TM-3) and seven (TM-7), and are associated with a very early age of onset which is consistent with a marked loss of function of the protein. The age of onset in the pedigree with Glu318Gly mutation was similar to that reported previously in a separate pedigree with this mutation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9831473     DOI: 10.1097/00001756-199810050-00034

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  9 in total

Review 1.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

2.  A novel PSEN2 p.Ser175Phe variant in a family with Alzheimer's disease.

Authors:  Gamze Guven; Bedia Samanci; Cagri Gulec; Hasmet Hanagasi; Hakan Gurvit; Ebru Erzurumluoglu Gokalp; Fatih Tepgec; Suleyman Guler; Oya Uyguner; Basar Bilgic
Journal:  Neurol Sci       Date:  2021-04-15       Impact factor: 3.307

3.  Early-onset familial Alzheimer's disease related to presenilin 1 mutation resembling autosomal dominant spinocerebellar ataxia.

Authors:  Pedro Braga-Neto; José Luiz Pedroso; Helena Alessi; Paulo Victor Sgobbi de Souza; Paulo Henrique Ferreira Bertolucci; Orlando Graziani Povoas Barsottini
Journal:  J Neurol       Date:  2013-03-13       Impact factor: 4.849

4.  A presenilin-1 mutation causes Alzheimer disease without affecting Notch signaling.

Authors:  Shuting Zhang; Fang Cai; Yili Wu; Tahereh Bozorgmehr; Zhe Wang; Si Zhang; Daochao Huang; Jifeng Guo; Lu Shen; Catharine Rankin; Beisha Tang; Weihong Song
Journal:  Mol Psychiatry       Date:  2018-06-18       Impact factor: 15.992

5.  Structure nor stability of the transmembrane spanning 6/7 domain of presenilin I correlates with pathogenicity.

Authors:  Brian Jeppesen; Laura Costello; Adam Fung; Erin Stanley; Jessica McDonald; Abbie Lambert; Bennett Johnson; Lisa Gentile
Journal:  Biochem Biophys Res Commun       Date:  2007-02-15       Impact factor: 3.575

Review 6.  Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy.

Authors:  Vitaly Vasilevko; Giselle F Passos; Daniel Quiring; Elizabeth Head; Richard C Kim; Mark Fisher; David H Cribbs
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

7.  Studies of the role of ubiquitination in the interaction of ubiquilin with the loop and carboxyl terminal regions of presenilin-2.

Authors:  Diana L Ford; Mervyn J Monteiro
Journal:  Biochemistry       Date:  2007-07-06       Impact factor: 3.162

Review 8.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

9.  A pathogenic PSEN1 Trp165Cys mutation associated with early-onset Alzheimer's disease.

Authors:  Vo Van Giau; Jung-Min Pyun; Jeewon Suh; Eva Bagyinszky; Seong Soo A An; Sang Yun Kim
Journal:  BMC Neurol       Date:  2019-08-07       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.